Treatment of autoimmune encephalitis with immune based therapies
June 6, 2017
The Journal of Neurology, Neuroscience, and Psychiatry reports on autoimmune encephalitis patients treated with immune based therapy including rituximab. Authors Dowland F, Swayne A, Bhuta S, et. al. discuss three cases and conclude, “The field of neuro-immunology has seen a plethora of newly discovered autoantibodies, yet there remain a significant number of patients, with features suggestive of an antibody-mediated pathophysiology, with inconclusive or negative results. Read the abstract of their work here.
Autoimmune encephalitis research can't wait — and neither can our patients.
We're in the final stretch of our month-long campaign to fund research that leads to faster diagnosis, better treatment, and one day a cure for autoimmune encephalitis. Every gift moves the science forward. Will you help today?
